Research and experimental development on natural sciences and engineering
ARXX THERAPEUTICS AS
Revenue 2024
NOK 5.0m
Operating profit
NOK −66.8m
Equity
NOK 13.5m
Incorporated
2015
Share capital
NOK 5.5m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 5.0m | |
| Total operating costs | 71.8m | |
| Operating profit (EBIT) | −66.8m | |
| Net financial items | −200k | |
| Profit for the year | −67.0m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 84.9m | |
| of which current assets | 84.7m | |
| Equity | 13.5m | |
| Total liabilities | 71.5m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.